An enterprise gateway for AI-model access, request security, budgets and routing.
CP
Canaan Partners
Activity from announced rounds
Activity in this selectionAI · Seed
Canaan Partners is an investment firm whose company directory identifies Draig Therapeutics and Solstice Oncology.
Recorded funding activity
Draig develops neuropsychiatric medicines, while Solstice advances an engineered CTLA-4 antibody for cancer treatment. The recorded history also includes Actualyze AI’s enterprise gateway for model access, request security, budgets and routing. Named regional funds retain separate identities.
Sources
- Rounds participated in
- 4
- Confirmed lead rounds
- 1 3 roles undisclosed
- New companies
- 4 First participation on record · 0 follow-on
- Funding in participating rounds
- $36.5M 4 disclosed · full round size, not this investor’s share
By stage
By primary sector
By country
Rounds
4 in this selectionActualyze AI
$7MSeed
Role not disclosedHeyMilo AI
Builds agentic recruiting platform that screens high-volume candidates via voice, video, SMS, and resume agents
$6MSeed
Role not disclosedSageOx
Builds shared context infrastructure for AI-native teams
$15MSeed
Role not disclosedRapidata
Rapidata supplies on-demand human feedback for training and evaluating AI models.
$8.5MSeed
Lead